BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 11772929)

  • 1. Potential pharmacokinetics interference between alpha-glucosidase inhibitors and other oral antidiabetic agents.
    Scheen AJ; Lefèbvre PJ
    Diabetes Care; 2002 Jan; 25(1):247-8. PubMed ID: 11772929
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pharmacokinetic, pharmacological, and clinical profile of miglitol (SEIBULE), a novel alpha-glucosidase inhibitor].
    Kuboyama N; Hayashi I; Yamaguchi T
    Nihon Yakurigaku Zasshi; 2006 Mar; 127(3):223-32. PubMed ID: 16651808
    [No Abstract]   [Full Text] [Related]  

  • 3. [Reducing postprandial glucose levels. Glucosidase antagonists].
    Neye H
    Pharm Unserer Zeit; 2002; 31(3):272-8. PubMed ID: 12071124
    [No Abstract]   [Full Text] [Related]  

  • 4. Improving management of type 2 diabetes mellitus: 1. alpha-Glucosidase inhibitors.
    Kuritzky L; Samraj G; Quillen DM
    Hosp Pract (1995); 1999 Sep; 34(10):43-6. PubMed ID: 10901748
    [No Abstract]   [Full Text] [Related]  

  • 5. [Current status of the treatment of type 2 diabetes mellitus. Alpha-glucosidase inhibitors].
    Blicklé JF; Andres E; Brogard JM
    Rev Med Interne; 1999 Aug; 20 Suppl 3():379s-383s. PubMed ID: 10480189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Alpha-glucosidase inhibitor in type 2 diabetic patients. Metabolism and body weight are favorably modified].
    Fehmann HC
    MMW Fortschr Med; 2001 Apr; 143(17):46. PubMed ID: 11490509
    [No Abstract]   [Full Text] [Related]  

  • 7. Miglitol, a new alpha-glucosidase inhibitor.
    Sels JP; Huijberts MS; Wolffenbuttel BH
    Expert Opin Pharmacother; 1999 Nov; 1(1):149-56. PubMed ID: 11249557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Continuation 50. Type 2 diabetes: possibilities and limitations of pharmacological therapy].
    Kellerer M; Jakob S; Linn T; Haslbeck M
    MMW Fortschr Med; 2003 Dec; 145(51-52):I-X; quiz XI-XII. PubMed ID: 14974337
    [No Abstract]   [Full Text] [Related]  

  • 9. Alpha-glucosidase inhibitors for type 2 diabetes mellitus.
    Van de Laar FA; Lucassen PL; Akkermans RP; Van de Lisdonk EH; Rutten GE; Van Weel C
    Cochrane Database Syst Rev; 2005 Apr; 2005(2):CD003639. PubMed ID: 15846673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Miglitol and hepatotoxicity in type 2 diabetes mellitus.
    Carlson RF
    Am Fam Physician; 2000 Jul; 62(2):315, 318. PubMed ID: 10929699
    [No Abstract]   [Full Text] [Related]  

  • 11. Potential of alpha-glucosidase inhibitors in elderly patients with diabetes mellitus and impaired glucose tolerance.
    Rabasa-Lhoret R; Chiasson JL
    Drugs Aging; 1998 Aug; 13(2):131-43. PubMed ID: 9739502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Miglitol for type 2 diabetes mellitus.
    Med Lett Drugs Ther; 1999 May; 41(1053):49-50. PubMed ID: 10368700
    [No Abstract]   [Full Text] [Related]  

  • 13. [Alpha-glucosidase inhibitor for type 2 diabetic patients. Clinical study with miglitol].
    Fehmann HC
    MMW Fortschr Med; 2000 May; 142(21):55. PubMed ID: 10872296
    [No Abstract]   [Full Text] [Related]  

  • 14. [Drug therapy of type 2 diabetes: insulin sensitizers improve results].
    Stadler HJ
    Pflege Z; 1999 Nov; 52(11):772-5. PubMed ID: 10788929
    [No Abstract]   [Full Text] [Related]  

  • 15. Chronic treatment of African-American type 2 diabetic patients with alpha-glucosidase inhibition.
    Johnston PS; Feig PU; Coniff RF; Krol A; Kelley DE; Mooradian AD
    Diabetes Care; 1998 Mar; 21(3):416-22. PubMed ID: 9540025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral pharmacologic management of type 2 diabetes.
    Riddle MC
    Am Fam Physician; 1999 Dec; 60(9):2613-20. PubMed ID: 10605995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of alpha-inhibitors on blood glucose and insulin levels.
    Laube H; Federlin K; Hillebrand I
    Adv Exp Med Biol; 1988; 246():287-93. PubMed ID: 3074658
    [No Abstract]   [Full Text] [Related]  

  • 18. [The alpha-glucosidase inhibitor miglitol for the treatment of type 2 diabetes mellitus in the doctor's office].
    Fehmann HC
    Fortschr Med Orig; 2001 Jul; 119 Suppl 2():55-61. PubMed ID: 15704357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is there a role for alpha-glucosidase inhibitors in the prevention of type 2 diabetes mellitus?
    Scheen AJ
    Drugs; 2003; 63(10):933-51. PubMed ID: 12699398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Miglitol: assessment of its role in the treatment of patients with diabetes mellitus.
    Campbell LK; Baker DE; Campbell RK
    Ann Pharmacother; 2000 Nov; 34(11):1291-301. PubMed ID: 11098345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.